PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
G vs. CDW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between G and CDW is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

G vs. CDW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Genpact Limited (G) and CDW Corporation (CDW). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
41.19%
-13.85%
G
CDW

Key characteristics

Sharpe Ratio

G:

1.86

CDW:

-0.69

Sortino Ratio

G:

3.52

CDW:

-0.75

Omega Ratio

G:

1.42

CDW:

0.89

Calmar Ratio

G:

1.31

CDW:

-0.57

Martin Ratio

G:

7.58

CDW:

-1.06

Ulcer Index

G:

7.15%

CDW:

18.09%

Daily Std Dev

G:

29.24%

CDW:

27.84%

Max Drawdown

G:

-64.14%

CDW:

-44.83%

Current Drawdown

G:

-1.91%

CDW:

-24.57%

Fundamentals

Market Cap

G:

$9.60B

CDW:

$25.92B

EPS

G:

$2.85

CDW:

$7.97

PE Ratio

G:

19.28

CDW:

24.40

PEG Ratio

G:

1.70

CDW:

1.53

Total Revenue (TTM)

G:

$4.77B

CDW:

$21.00B

Gross Profit (TTM)

G:

$1.67B

CDW:

$4.60B

EBITDA (TTM)

G:

$810.53M

CDW:

$1.86B

Returns By Period

In the year-to-date period, G achieves a 26.85% return, which is significantly higher than CDW's 10.78% return. Over the past 10 years, G has underperformed CDW with an annualized return of 10.50%, while CDW has yielded a comparatively higher 18.97% annualized return.


G

YTD

26.85%

1M

18.02%

6M

41.19%

1Y

54.91%

5Y*

5.84%

10Y*

10.50%

CDW

YTD

10.78%

1M

0.63%

6M

-13.85%

1Y

-19.20%

5Y*

8.84%

10Y*

18.97%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

G vs. CDW — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

G
The Risk-Adjusted Performance Rank of G is 9090
Overall Rank
The Sharpe Ratio Rank of G is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of G is 9494
Sortino Ratio Rank
The Omega Ratio Rank of G is 9191
Omega Ratio Rank
The Calmar Ratio Rank of G is 8484
Calmar Ratio Rank
The Martin Ratio Rank of G is 8787
Martin Ratio Rank

CDW
The Risk-Adjusted Performance Rank of CDW is 1515
Overall Rank
The Sharpe Ratio Rank of CDW is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of CDW is 1515
Sortino Ratio Rank
The Omega Ratio Rank of CDW is 1313
Omega Ratio Rank
The Calmar Ratio Rank of CDW is 1313
Calmar Ratio Rank
The Martin Ratio Rank of CDW is 2121
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

G vs. CDW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Genpact Limited (G) and CDW Corporation (CDW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for G, currently valued at 1.86, compared to the broader market-2.000.002.001.86-0.69
The chart of Sortino ratio for G, currently valued at 3.52, compared to the broader market-4.00-2.000.002.004.006.003.52-0.75
The chart of Omega ratio for G, currently valued at 1.42, compared to the broader market0.501.001.502.001.420.89
The chart of Calmar ratio for G, currently valued at 1.31, compared to the broader market0.002.004.006.001.31-0.57
The chart of Martin ratio for G, currently valued at 7.58, compared to the broader market-10.000.0010.0020.0030.007.58-1.06
G
CDW

The current G Sharpe Ratio is 1.86, which is higher than the CDW Sharpe Ratio of -0.69. The chart below compares the historical Sharpe Ratios of G and CDW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
1.86
-0.69
G
CDW

Dividends

G vs. CDW - Dividend Comparison

G's dividend yield for the trailing twelve months is around 1.12%, less than CDW's 1.29% yield.


TTM20242023202220212020201920182017201620152014
G
Genpact Limited
1.12%1.42%1.59%1.08%0.81%0.95%0.81%1.11%0.76%0.00%0.00%0.00%
CDW
CDW Corporation
1.29%1.43%1.05%1.17%0.83%1.17%0.89%1.14%0.99%0.93%0.74%0.56%

Drawdowns

G vs. CDW - Drawdown Comparison

The maximum G drawdown since its inception was -64.14%, which is greater than CDW's maximum drawdown of -44.83%. Use the drawdown chart below to compare losses from any high point for G and CDW. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-1.91%
-24.57%
G
CDW

Volatility

G vs. CDW - Volatility Comparison

Genpact Limited (G) has a higher volatility of 11.15% compared to CDW Corporation (CDW) at 7.51%. This indicates that G's price experiences larger fluctuations and is considered to be riskier than CDW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%SeptemberOctoberNovemberDecember2025February
11.15%
7.51%
G
CDW

Financials

G vs. CDW - Financials Comparison

This section allows you to compare key financial metrics between Genpact Limited and CDW Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab